Patents Assigned to QR PHARMA
  • Publication number: 20180228771
    Abstract: One of the aspects of the invention is directed toward a method of treating or preventing acute brain or nerve injury in a subject, comprising administering an effective amount of posiphen, or a pharmaceutically acceptable salt of posiphen, to the subject in need thereof. Similarly, another aspect of the invention is directed toward a use of posiphen, or a pharmaceutically acceptable salt of posiphen, for the treatment or prevention of acute brain or nerve injury. Preferably, the posiphen in the method or use of the invention is posiphen tartrate.
    Type: Application
    Filed: August 12, 2016
    Publication date: August 16, 2018
    Applicant: QR PHARMA
    Inventor: Maria Maccecchini